Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allegro Evaluation Study for FDA Submission

NCT04096313 is registered in ClinicalTrials.gov with Nova Biomedical as lead sponsor.

NCT NCT04096313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04096313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allegro Evaluation Study for FDA Submission
Lead sponsor
Nova Biomedical
Phase
Observational
Overall status
Completed
Start date
March 25, 2020
Completion date
December 15, 2021
Enrollment
628 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, kidney diseases, metabolic disease